Showing results (41-50 of 45) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Medicinal Chemistry|April 10, 1999
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacementsP S Dragovich, T J Prins, R Zhou, et al.Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypesD A Matthews, P S Dragovich, S E Webber, et al.Journal of Medicinal Chemistry|December 16, 1997
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 proteaseS W Kaldor, V J Kalish, J F Davies, et al.Journal of Medicinal Chemistry|July 21, 1998
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studiesP S Dragovich, S E Webber, R E Babine, et al.Journal of Medicinal Chemistry|July 21, 1998
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studiesP S Dragovich, S E Webber, R E Babine, et al.Pageof 5